HZNP Overview
Upcoming Projects (HZNP)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (HZNP)
-
A Second Take: Discussing targets in TED (IGF-1R, IL-6 & FcRn class), including their available clinical data.
Tickers: HZNP, VRDN, IMVT, ARGX
Executed On: Sep 19, 2023 at 09:45 AM EDT -
Discussing targets in TED (IGF-1R, IL-6 & FcRn class), including their available clinical data.
Tickers: HZNP, VRDN, IMVT, ARGX
Executed On: Sep 18, 2023 at 07:30 PM EDT -
Discussing the FDA warning label for Horizon's Tepezza for TED and how severe hearing-related side effects may alter prescribing patterns
Ticker: HZNP
Executed On: Jul 28, 2023 at 12:30 PM EDT -
A Second Look: Discussing the Topline Data from TEPEZZA (teprotutumab) in phase 4 Clinical Trial in Patients with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED)
Ticker: HZNP
Executed On: May 23, 2023 at 06:00 PM EDT -
Exploring the TED treatment landscape with an ophthalmologist focusing on Horizon's Tepezza (teprotumumab-trbw), Immunovant's Batoclimab (IMVT-1401), and Viridian's VRDN-001.
Tickers: HZNP, VRDN, IMVT
Executed On: May 23, 2023 at 05:30 PM EDT -
Discussing the Topline Data from TEPEZZA (teprotutumab) in phase 4 Clinical Trial in Patients with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED)
Ticker: HZNP
Executed On: May 22, 2023 at 01:00 PM EDT -
Digging into the Phase 2 data on Horizon's dazodalibep for Sjögren’s Syndrome
Tickers: HZNP, AMGN
Executed On: Jan 27, 2023 at 05:00 PM EST -
An updated view on Tepezza in Thyroid Eye Disease
Ticker: HZNP
Executed On: Aug 11, 2022 at 04:00 PM EDT -
A look at Uplizna (inebilizumab) in patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
Ticker: HZNP
Executed On: Jul 20, 2022 at 03:00 PM EDT -
Second Opinion: Discussion of Tepezza following the pooled data update from ENDO 2022
Ticker: HZNP
Executed On: Jun 27, 2022 at 10:00 AM EDT -
Discussion of Tepezza following the pooled data update from ENDO 2022
Ticker: HZNP
Executed On: Jun 21, 2022 at 10:45 AM EDT -
Discussing the use and potential FDA Approval of adding methotrexate to KRYSTEXXA(pegloticase) in patients with uncontrolled gout
Ticker: HZNP
Executed On: Jun 17, 2022 at 04:00 PM EDT -
A Third Opinion: Discussing Tepezza's launch and remaining unmet medical need in treating Thyroid Eye Disease (TED)
Tickers: HZNP, VRDN, ValenzaBio, VasaraGen
Executed On: Feb 01, 2022 at 12:40 PM EST -
A Second Opinion: Discussing Tepezza's launch and remaining unmet medical need in treating Thyroid Eye Disease (TED)
Tickers: HZNP, VRDN, ValenzaBio, VasaraGen
Executed On: Jan 27, 2022 at 07:00 PM EST -
Discussing Tepezza's launch and remaining unmet medical need in treating Thyroid Eye Disease (TED)
Tickers: HZNP, VRDN, ValenzaBio, VasaraGen
Executed On: Jan 26, 2022 at 02:00 PM EST
Expired Projects (HZNP)
-
An Analysis of the Market Potential in US of Raptor Pharmaceutical's Quisair (Inhaled Levofloxacin) for Cystic Fibrosis if Approved
Tickers: HZNP, RPTP
Execute By: Oct 19, 2016
Upcoming & Overdue Catalysts (HZNP)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (HZNP)
-
Canada Accepts NDA for Procysbi and Grants Priority Review - Decision on Approval Expected By June 2017
Tickers: RPTP, HZNP
Occurred on: Jun 19, 2017 -
Quinsair for treatment of cystic fibrosis to Commercially Launch in Canada in H2 of 2016
Tickers: RPTP, HZNP
Occurred on: Dec 22, 2016 -
Phase 3 data of ACTIMMUNE for Friedreich's Ataxia due by end of 2016
Ticker: HZNP
Occurred on: Dec 08, 2016 -
Horizon Pharma (HZNP) Down 17% After Negative NY Times Article On High Price of Arthritis Pill Duexis
Ticker: HZNP
Occurred on: Oct 20, 2015
Strategic Initiatives (HZNP)
-
Horizon Pharma plc (HZNP) Complete Acquisition of Raptor Pharmaceutical Corp. (RPTP)
Tickers: HZNP, RPTP
Announcement Date: Oct 25, 2016
